Wuxi Hyatech Co

Wuxi Hyatech Co ROE

The Return on Equity (ROE) of Wuxi Hyatech Co (688510.SS) as of Oct 22, 2026 is 8.45 %. In the previous year, Return on Equity (ROE) was 11.08 % — a change of -23.70% (lower).

ROE

8.45 %

YoY

-23.70%

Last updated:

In 2025, Wuxi Hyatech Co's return on equity (ROE) was 8.45 %, a -23.70% increase from the 11.08 % ROE in the previous year.

The Wuxi Hyatech Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
3.83 CNY
Jan 1, 2019
10.40 CNY
Jan 1, 2020
6.37 CNY
Jan 1, 2021
2.53 CNY
Jan 1, 2022
2.10 CNY
Jan 1, 2023
8.60 CNY
Jan 1, 2024
11.08 CNY
Jan 1, 2025
8.45 CNY
The Wuxi Hyatech Co ROE history
YEARROEYoY
8.45 %-23.70%
11.08 %+28.84%
8.60 %+310.44%
2.10 %-17.08%
2.53 %-60.36%
6.37 %-38.72%
10.40 %+171.52%
3.83 %-193.21%
-4.11 %-68.02%
-12.85 %+8.07%
-11.89 %-50.09%
-23.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wuxi Hyatech Co Stock analysis

What does Wuxi Hyatech Co do? Wuxi Hyatech Co Ltd generates revenue through the research and development, manufacturing, and sales of key components for aero-engines and medical orthopedic implant forgings. The company produces high-performance components including aviation turbofan engine compressor blades, rotating parts, and structural parts, which are sold domestically and internationally. Its primary customers are aerospace manufacturers and medical device companies requiring specialized forgings for engine parts and orthopedic implants. The firm targets the aerospace and medical sectors with its focus on precision-engineered components for critical applications. The company's product portfolio includes aviation turbofan engine compressor blades, rotating parts, and structural parts, alongside medical orthopedic implant forgings. These products are distributed across domestic and overseas markets, serving both the Chinese aerospace industry and international medical device markets. Wuxi Hyatech's revenue streams are derived from direct sales of these specialized components to industrial and medical clients without third-party intermediaries. Wuxi Hyatech's business model centers on supplying high-precision components for aero-engines and medical orthopedic implants. The company's manufacturing capabilities enable it to produce critical parts for aircraft engines and orthopedic devices, with a focus on domestic and international industrial clients. Revenue is generated through the sale of these specialized forgings to aerospace and medical sectors, leveraging its R&D expertise in component production. Wuxi Hyatech Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Wuxi Hyatech Co's Return on Equity (ROE)

Wuxi Hyatech Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Wuxi Hyatech Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Wuxi Hyatech Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Wuxi Hyatech Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Wuxi Hyatech Co stock

Return on Equity (ROE) of Wuxi Hyatech Co is 8.45 % in 2025.

Return on Equity (ROE) of Wuxi Hyatech Co changed from 11.08 % to 8.45 %, representing a -23.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Wuxi Hyatech Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Wuxi Hyatech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Wuxi Hyatech Co

All Key Metrics — Wuxi Hyatech Co